GAMMA Investing LLC Acquires 209 Shares of Cabot Corporation $CBT

GAMMA Investing LLC boosted its position in Cabot Corporation (NYSE:CBT) by 12.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,909 shares of the specialty chemicals company’s stock after buying an additional 209 shares during the quarter. GAMMA Investing LLC’s holdings in Cabot were worth $143,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Beverly Hills Private Wealth LLC increased its holdings in shares of Cabot by 3.6% during the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company’s stock worth $326,000 after acquiring an additional 135 shares during the last quarter. Keeley Teton Advisors LLC lifted its position in shares of Cabot by 1.0% during the 1st quarter. Keeley Teton Advisors LLC now owns 16,756 shares of the specialty chemicals company’s stock valued at $1,393,000 after acquiring an additional 174 shares during the period. Isthmus Partners LLC lifted its position in shares of Cabot by 4.6% during the 1st quarter. Isthmus Partners LLC now owns 4,258 shares of the specialty chemicals company’s stock valued at $354,000 after acquiring an additional 186 shares during the period. Ferguson Wellman Capital Management Inc. lifted its position in shares of Cabot by 4.2% during the 2nd quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company’s stock worth $375,000 after buying an additional 200 shares during the last quarter. Finally, CWM LLC lifted its position in shares of Cabot by 55.0% during the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company’s stock worth $50,000 after buying an additional 213 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Stock Down 1.4%

Shares of NYSE:CBT opened at $76.15 on Tuesday. The business’s 50 day simple moving average is $78.31 and its two-hundred day simple moving average is $77.76. The firm has a market cap of $4.05 billion, a P/E ratio of 9.95 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. Cabot Corporation has a 52-week low of $70.40 and a 52-week high of $117.46.

Cabot (NYSE:CBT) last posted its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. The company had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. As a group, research analysts forecast that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Cabot Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 11th. Stockholders of record on Friday, August 29th were given a $0.45 dividend. The ex-dividend date was Friday, August 29th. This represents a $1.80 annualized dividend and a dividend yield of 2.4%. Cabot’s payout ratio is 23.53%.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 114,436 shares of Cabot stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the transaction, the chief executive officer directly owned 361,518 shares in the company, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 3.03% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, UBS Group set a $82.00 target price on Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $92.33.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.